Evaluation of Safety and Side Effects COVID-19 Vaccine in Cancer Patients Being Treated.
COVID-19 vaccines
Side effect
Sinopharm
cancer
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
15
10
2021
entrez:
29
4
2022
pubmed:
30
4
2022
medline:
3
5
2022
Statut:
epublish
Résumé
According to the instructions of Iran's National Corona Response Committee in the Iranian Ministry of Health and Medical Education, patients undergoing treatments for their cancer are prioritized in Covid-19 vaccination. The present study was therefore conducted to investigate the toxicity and acute side-effects of a Covid-19 vaccine in cancer patients presenting to Medical Oncology Clinic of Kermanshah University of Medical Science. After excluding the patients with active infection and the recently-infected ones with Covid-19, they underwent the vaccination. The patients with cell counts exceeding 3,000 received two doses of the vaccine with a 21-day interval and treatment of their underlying disease was postponed for 7 days. The side-effects were mild and tolerable and included fever (case 10), pain at the injection site (7), dizziness (7), body pain (6), abdominal pain (6), myalgia (6), headache (6), chills (3), shortness of breath (3), diarrhea (1), runny nose (1) and dryness of the throat (1). No significant toxicity was reported in the patients who were safely vaccinated under the supervision of the medical oncology clinic.
Identifiants
pubmed: 35485684
doi: 10.31557/APJCP.2022.23.4.1263
pmc: PMC9375605
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1263-1270Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Cancer Invest. 2022 Jan;40(1):26-34
pubmed: 34634986
BMC Infect Dis. 2022 Jan 20;22(1):70
pubmed: 35057745
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
Cancer. 2021 May 1;127(9):1459-1468
pubmed: 33378122
JAMA Oncol. 2021 Feb 1;7(2):220-227
pubmed: 33300956
Front Psychol. 2020 Dec 15;11:572699
pubmed: 33384638
Signal Transduct Target Ther. 2020 Oct 13;5(1):237
pubmed: 33051445
Ann Hematol. 2021 Feb;100(2):383-393
pubmed: 33159569
BMC Infect Dis. 2021 Jul 16;21(1):685
pubmed: 34266396
Int Immunopharmacol. 2014 Jan;18(1):90-7
pubmed: 24269583
Ann Clin Transl Neurol. 2021 Oct;8(10):2000-2003
pubmed: 34480527
JCO Glob Oncol. 2021 Feb;7:311-323
pubmed: 33617304
JAMA Netw Open. 2021 Dec 1;4(12):e2140364
pubmed: 34935921
Int J Clin Oncol. 2020 Sep;25(9):1581-1586
pubmed: 32654049
Int J Infect Dis. 2020 May;94:44-48
pubmed: 32171952
Medicine (Baltimore). 2022 Jan 14;101(2):e28561
pubmed: 35029223
J Hematol Oncol. 2021 Feb 27;14(1):38
pubmed: 33640005
Clin Med Insights Oncol. 2022 Jan 28;16:11795549221074168
pubmed: 35110966
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Clin Pharmacol. 2018 Jan;58(1):7-24
pubmed: 29136276
Lancet Oncol. 2021 Jun;22(6):765-778
pubmed: 33930323
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Blood. 2013 Jul 11;122(2):227-38
pubmed: 23719297
Int J Cancer. 2020 Dec 1;147(11):3267-3269
pubmed: 32525566
Am J Health Syst Pharm. 2022 Jan 5;79(2):63-71
pubmed: 34455440
Cancer Rep (Hoboken). 2021 Oct;4(5):e1378
pubmed: 33742793
Front Psychol. 2020 Oct 02;11:566212
pubmed: 33117234